A glance at what’s happening in the world of technology - Winter 2023.
Gene therapy for Stargardt disease in the offing
Scientists at the National Eye Institute have found the first direct evidence that Stargardt-related ABCA4 gene mutations affect the retinal pigment epithelium (RPE).
The discovery points to a new understanding of the progression of this rare inherited blinding disease and suggests a therapeutic strategy. The research team used a new stem cell-based model made from skin cells, according to the study published in Stem Cell Reports.
Sign in to continue
Not already a member of the College?
Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
The College have provided key information to help you identify of cases and guidance on managing circumstances that are relevant to optometry practices.